Global Histone Deacetylase (HDAC) Inhibitors Market Growth 2020-2025
According to this study, over the next five years the Histone Deacetylase (HDAC) Inhibitors market will register a xx%% CAGR in terms of revenue, the global market size will reach $ xx million by 2025, from $ xx million in 2019. In particular, this report presents the global market share (sales and revenue) of key companies in Histone Deacetylase (HDAC) Inhibitors business, shared in Chapter 3.
This report presents a comprehensive overview, market shares, and growth opportunities of Histone Deacetylase (HDAC) Inhibitors market by product type, application, key manufacturers and key regions and countries.
This study specially analyses the impact of Covid-19 outbreak on the Histone Deacetylase (HDAC) Inhibitors, covering the supply chain analysis, impact assessment to the Histone Deacetylase (HDAC) Inhibitors market size growth rate in several scenarios, and the measures to be undertaken by Histone Deacetylase (HDAC) Inhibitors companies in response to the COVID-19 epidemic.
Segmentation by type: breakdown data from 2015 to 2020, in Section 2.3; and forecast to 2025 in section 11.7.
Fatty Acid
Hydroxamate
Cyclic Peptide
Benzamide
Segmentation by application: breakdown data from 2015 to 2020, in Section 2.4; and forecast to 2024 in section 11.8.
Treatment of Malignant Tumors
Chronic Disease Treatment
Others
This report also splits the market by region: Breakdown data in Chapter 4, 5, 6, 7 and 8.
Americas
United States
Canada
Mexico
Brazil
APAC
China
Japan
Korea
Southeast Asia
India
Australia
Europe
Germany
France
UK
Italy
Russia
Middle East & Africa
Egypt
South Africa
Israel
Turkey
GCC Countries
The report also presents the market competition landscape and a corresponding detailed analysis of the major vendor/manufacturers in the market. The key manufacturers covered in this report: Breakdown data in in Chapter 3.
4SC
Novartis
Acetylon Pharmaceuticals
Chipscreen Biosciences
Chroma Therapeutics
Celleron Therapeutics
MEI Pharma
CrystalGenomics
Mirati Therapeutics
Curis
Onxeo
TetraLogic
Repligen
In addition, this report discusses the key drivers influencing market growth, opportunities, the challenges and the risks faced by key manufacturers and the market as a whole. It also analyzes key emerging trends and their impact on present and future development.
Research objectives
To study and analyze the global Histone Deacetylase (HDAC) Inhibitors consumption (value & volume) by key regions/countries, type and application, history data from 2015 to 2019, and forecast to 2025.
To understand the structure of Histone Deacetylase (HDAC) Inhibitors market by identifying its various subsegments.
Focuses on the key global Histone Deacetylase (HDAC) Inhibitors manufacturers, to define, describe and analyze the sales volume, value, market share, market competition landscape, SWOT analysis and development plans in next few years.
To analyze the Histone Deacetylase (HDAC) Inhibitors with respect to individual growth trends, future prospects, and their contribution to the total market.
To share detailed information about the key factors influencing the growth of the market (growth potential, opportunities, drivers, industry-specific challenges and risks).
To project the consumption of Histone Deacetylase (HDAC) Inhibitors submarkets, with respect to key regions (along with their respective key countries).
To analyze competitive developments such as expansions, agreements, new product launches, and acquisitions in the market.
To strategically profile the key players and comprehensively analyze their growth strategies.
1 Scope of the Report
1.1 Market Introduction
1.2 Research Objectives
1.3 Years Considered
1.4 Market Research Methodology
1.5 Data Source
1.6 Economic Indicators
1.7 Currency Considered
2 Executive Summary
2.1 World Market Overview
2.1.1 Global Histone Deacetylase (HDAC) Inhibitors Consumption 2015-2025
2.1.2 Histone Deacetylase (HDAC) Inhibitors Consumption CAGR by Region
2.2 Histone Deacetylase (HDAC) Inhibitors Segment by Type
2.2.1 Fatty Acid
2.2.2 Hydroxamate
2.2.3 Cyclic Peptide
2.2.4 Benzamide
2.3 Histone Deacetylase (HDAC) Inhibitors Consumption by Type
2.3.1 Global Histone Deacetylase (HDAC) Inhibitors Consumption Market Share by Type (2015-2020)
2.3.2 Global Histone Deacetylase (HDAC) Inhibitors Revenue and Market Share by Type (2015-2020)
2.3.3 Global Histone Deacetylase (HDAC) Inhibitors Sale Price by Type (2015-2020)
2.4 Histone Deacetylase (HDAC) Inhibitors Segment by Application
2.4.1 Treatment of Malignant Tumors
2.4.2 Chronic Disease Treatment
2.4.3 Others
2.5 Histone Deacetylase (HDAC) Inhibitors Consumption by Application
2.5.1 Global Histone Deacetylase (HDAC) Inhibitors Consumption Market Share by Type (2015-2020)
2.5.2 Global Histone Deacetylase (HDAC) Inhibitors Value and Market Share by Type (2015-2020)
2.5.3 Global Histone Deacetylase (HDAC) Inhibitors Sale Price by Type (2015-2020)
3 Global Histone Deacetylase (HDAC) Inhibitors by Company
3.1 Global Histone Deacetylase (HDAC) Inhibitors Sales Market Share by Company
3.1.1 Global Histone Deacetylase (HDAC) Inhibitors Sales by Company (2018-2020)
3.1.2 Global Histone Deacetylase (HDAC) Inhibitors Sales Market Share by Company (2018-2020)
3.2 Global Histone Deacetylase (HDAC) Inhibitors Revenue Market Share by Company
3.2.1 Global Histone Deacetylase (HDAC) Inhibitors Revenue by Company (2018-2020)
3.2.2 Global Histone Deacetylase (HDAC) Inhibitors Revenue Market Share by Company (2018-2020)
3.3 Global Histone Deacetylase (HDAC) Inhibitors Sale Price by Company
3.4 Global Histone Deacetylase (HDAC) Inhibitors Manufacturing Base Distribution, Sales Area, Type by Company
3.4.1 Global Histone Deacetylase (HDAC) Inhibitors Manufacturing Base Distribution and Sales Area by Company
3.4.2 Players Histone Deacetylase (HDAC) Inhibitors Products Offered
3.5 Market Concentration Rate Analysis
3.5.1 Competition Landscape Analysis
3.5.2 Concentration Ratio (CR3, CR5 and CR10) (2018-2020)
3.6 New Products and Potential Entrants
3.7 Mergers & Acquisitions, Expansion
4 Histone Deacetylase (HDAC) Inhibitors by Regions
4.1 Histone Deacetylase (HDAC) Inhibitors by Regions
4.2 Americas Histone Deacetylase (HDAC) Inhibitors Consumption Growth
4.3 APAC Histone Deacetylase (HDAC) Inhibitors Consumption Growth
4.4 Europe Histone Deacetylase (HDAC) Inhibitors Consumption Growth
4.5 Middle East & Africa Histone Deacetylase (HDAC) Inhibitors Consumption Growth
5 Americas
5.1 Americas Histone Deacetylase (HDAC) Inhibitors Consumption by Countries
5.1.1 Americas Histone Deacetylase (HDAC) Inhibitors Consumption by Countries (2015-2020)
5.1.2 Americas Histone Deacetylase (HDAC) Inhibitors Value by Countries (2015-2020)
5.2 Americas Histone Deacetylase (HDAC) Inhibitors Consumption by Type
5.3 Americas Histone Deacetylase (HDAC) Inhibitors Consumption by Application
5.4 United States
5.5 Canada
5.6 Mexico
5.7 Brazil
5.8 Key Economic Indicators of Few Americas Countries
6 APAC
6.1 APAC Histone Deacetylase (HDAC) Inhibitors Consumption by Regions
6.1.1 APAC Histone Deacetylase (HDAC) Inhibitors Consumption by Regions (2015-2020)
6.1.2 APAC Histone Deacetylase (HDAC) Inhibitors Value by Regions (2015-2020)
6.2 APAC Histone Deacetylase (HDAC) Inhibitors Consumption by Type
6.3 APAC Histone Deacetylase (HDAC) Inhibitors Consumption by Application
6.4 China
6.5 Japan
6.6 Korea
6.7 Southeast Asia
6.8 India
6.9 Australia
6.10 Key Economic Indicators of Few APAC Regions
7 Europe
7.1 Europe Histone Deacetylase (HDAC) Inhibitors by Countries
7.1.1 Europe Histone Deacetylase (HDAC) Inhibitors Consumption by Countries (2015-2020)
7.1.2 Europe Histone Deacetylase (HDAC) Inhibitors Value by Countries (2015-2020)
7.2 Europe Histone Deacetylase (HDAC) Inhibitors Consumption by Type
7.3 Europe Histone Deacetylase (HDAC) Inhibitors Consumption by Application
7.4 Germany
7.5 France
7.6 UK
7.7 Italy
7.8 Russia
7.9 Key Economic Indicators of Few Europe Countries
8 Middle East & Africa
8.1 Middle East & Africa Histone Deacetylase (HDAC) Inhibitors by Countries
8.1.1 Middle East & Africa Histone Deacetylase (HDAC) Inhibitors Consumption by Countries (2015-2020)
8.1.2 Middle East & Africa Histone Deacetylase (HDAC) Inhibitors Value by Countries (2015-2020)
8.2 Middle East & Africa Histone Deacetylase (HDAC) Inhibitors Consumption by Type
8.3 Middle East & Africa Histone Deacetylase (HDAC) Inhibitors Consumption by Application
8.4 Egypt
8.5 South Africa
8.6 Israel
8.7 Turkey
8.8 GCC Countries
9 Market Drivers, Challenges and Trends
9.1 Market Drivers and Impact
9.1.1 Growing Demand from Key Regions
9.1.2 Growing Demand from Key Applications and Potential Industries
9.2 Market Challenges and Impact
9.3 Market Trends
10 Marketing, Distributors and Customer
10.1 Sales Channel
10.1.1 Direct Channels
10.1.2 Indirect Channels
10.2 Histone Deacetylase (HDAC) Inhibitors Distributors
10.3 Histone Deacetylase (HDAC) Inhibitors Customer
11 Global Histone Deacetylase (HDAC) Inhibitors Market Forecast
11.1 Global Histone Deacetylase (HDAC) Inhibitors Consumption Forecast (2021-2025)
11.2 Global Histone Deacetylase (HDAC) Inhibitors Forecast by Regions
11.2.1 Global Histone Deacetylase (HDAC) Inhibitors Forecast by Regions (2021-2025)
11.2.2 Global Histone Deacetylase (HDAC) Inhibitors Value Forecast by Regions (2021-2025)
11.2.3 Americas Consumption Forecast
11.2.4 APAC Consumption Forecast
11.2.5 Europe Consumption Forecast
11.2.6 Middle East & Africa Consumption Forecast
11.3 Americas Forecast by Countries
11.3.1 United States Market Forecast
11.3.2 Canada Market Forecast
11.3.3 Mexico Market Forecast
11.3.4 Brazil Market Forecast
11.4 APAC Forecast byRegions
11.4.1 China Market Forecast
11.4.2 Japan Market Forecast
11.4.3 Korea Market Forecast
11.4.4 Southeast Asia Market Forecast
11.4.5 India Market Forecast
11.4.6 Australia Market Forecast
11.5 Europe Forecast by Countries
11.5.1 Germany Market Forecast
11.5.2 France Market Forecast
11.5.3 UK Market Forecast
11.5.4 Italy Market Forecast
11.5.5 Russia Market Forecast
11.6 Middle East & Africa Forecast by Countries
11.6.1 Egypt Market Forecast
11.6.2 South Africa Market Forecast
11.6.3 Israel Market Forecast
11.6.4 Turkey Market Forecast
11.6.5 GCC Countries Market Forecast
11.7 Global Histone Deacetylase (HDAC) Inhibitors Forecast by Type
11.8 Global Histone Deacetylase (HDAC) Inhibitors Forecast by Application
12 Key Players Analysis
12.1 4SC
12.1.1 Company Information
12.1.2 Histone Deacetylase (HDAC) Inhibitors Product Offered
12.1.3 4SC Histone Deacetylase (HDAC) Inhibitors Sales, Revenue, Price and Gross Margin (2018-2020)
12.1.4 Main Business Overview
12.1.5 4SC Latest Developments
12.2 Novartis
12.2.1 Company Information
12.2.2 Histone Deacetylase (HDAC) Inhibitors Product Offered
12.2.3 Novartis Histone Deacetylase (HDAC) Inhibitors Sales, Revenue, Price and Gross Margin (2018-2020)
12.2.4 Main Business Overview
12.2.5 Novartis Latest Developments
12.3 Acetylon Pharmaceuticals
12.3.1 Company Information
12.3.2 Histone Deacetylase (HDAC) Inhibitors Product Offered
12.3.3 Acetylon Pharmaceuticals Histone Deacetylase (HDAC) Inhibitors Sales, Revenue, Price and Gross Margin (2018-2020)
12.3.4 Main Business Overview
12.3.5 Acetylon Pharmaceuticals Latest Developments
12.4 Chipscreen Biosciences
12.4.1 Company Information
12.4.2 Histone Deacetylase (HDAC) Inhibitors Product Offered
12.4.3 Chipscreen Biosciences Histone Deacetylase (HDAC) Inhibitors Sales, Revenue, Price and Gross Margin (2018-2020)
12.4.4 Main Business Overview
12.4.5 Chipscreen Biosciences Latest Developments
12.5 Chroma Therapeutics
12.5.1 Company Information
12.5.2 Histone Deacetylase (HDAC) Inhibitors Product Offered
12.5.3 Chroma Therapeutics Histone Deacetylase (HDAC) Inhibitors Sales, Revenue, Price and Gross Margin (2018-2020)
12.5.4 Main Business Overview
12.5.5 Chroma Therapeutics Latest Developments
12.6 Celleron Therapeutics
12.6.1 Company Information
12.6.2 Histone Deacetylase (HDAC) Inhibitors Product Offered
12.6.3 Celleron Therapeutics Histone Deacetylase (HDAC) Inhibitors Sales, Revenue, Price and Gross Margin (2018-2020)
12.6.4 Main Business Overview
12.6.5 Celleron Therapeutics Latest Developments
12.7 MEI Pharma
12.7.1 Company Information
12.7.2 Histone Deacetylase (HDAC) Inhibitors Product Offered
12.7.3 MEI Pharma Histone Deacetylase (HDAC) Inhibitors Sales, Revenue, Price and Gross Margin (2018-2020)
12.7.4 Main Business Overview
12.7.5 MEI Pharma Latest Developments
12.8 CrystalGenomics
12.8.1 Company Information
12.8.2 Histone Deacetylase (HDAC) Inhibitors Product Offered
12.8.3 CrystalGenomics Histone Deacetylase (HDAC) Inhibitors Sales, Revenue, Price and Gross Margin (2018-2020)
12.8.4 Main Business Overview
12.8.5 CrystalGenomics Latest Developments
12.9 Mirati Therapeutics
12.9.1 Company Information
12.9.2 Histone Deacetylase (HDAC) Inhibitors Product Offered
12.9.3 Mirati Therapeutics Histone Deacetylase (HDAC) Inhibitors Sales, Revenue, Price and Gross Margin (2018-2020)
12.9.4 Main Business Overview
12.9.5 Mirati Therapeutics Latest Developments
12.10 Curis
12.10.1 Company Information
12.10.2 Histone Deacetylase (HDAC) Inhibitors Product Offered
12.10.3 Curis Histone Deacetylase (HDAC) Inhibitors Sales, Revenue, Price and Gross Margin (2018-2020)
12.10.4 Main Business Overview
12.10.5 Curis Latest Developments
12.11 Onxeo
12.11.1 Company Information
12.11.2 Histone Deacetylase (HDAC) Inhibitors Product Offered
12.11.3 Onxeo Histone Deacetylase (HDAC) Inhibitors Sales, Revenue, Price and Gross Margin (2018-2020)
12.11.4 Main Business Overview
12.11.5 Onxeo Latest Developments
12.12 TetraLogic
12.12.1 Company Information
12.12.2 Histone Deacetylase (HDAC) Inhibitors Product Offered
12.12.3 TetraLogic Histone Deacetylase (HDAC) Inhibitors Sales, Revenue, Price and Gross Margin (2018-2020)
12.12.4 Main Business Overview
12.12.5 TetraLogic Latest Developments
12.13 Repligen
12.13.1 Company Information
12.13.2 Histone Deacetylase (HDAC) Inhibitors Product Offered
12.13.3 Repligen Histone Deacetylase (HDAC) Inhibitors Sales, Revenue, Price and Gross Margin (2018-2020)
12.13.4 Main Business Overview
12.13.5 Repligen Latest Developments
13 Research Findings and Conclusion
Tables and Figures
List of Tables
Table 1. Research Methodology
Table 2. Data Source
Table 3. Histone Deacetylase (HDAC) Inhibitors Consumption CAGR by Region 2015-2025 ($ Millions)
Table 4. Major Players of Fatty Acid
Table 5. Major Players of Hydroxamate
Table 6. Major Players of Cyclic Peptide
Table 7. Major Players of Benzamide
Table 8. Global Consumption Sales by Type (2015-2020)
Table 9. Global Histone Deacetylase (HDAC) Inhibitors Consumption Market Share by Type (2015-2020)
Table 10. Global Histone Deacetylase (HDAC) Inhibitors Revenue by Type (2015-2020) ($ million)
Table 11. Global Histone Deacetylase (HDAC) Inhibitors Value Market Share by Type (2015-2020) ($ Millions)
Table 12. Global Histone Deacetylase (HDAC) Inhibitors Sale Price by Type (2015-2020)
Table 13. Global Consumption Sales by Application (2015-2020)
Table 14. Global Histone Deacetylase (HDAC) Inhibitors Consumption Market Share by Application (2015-2020)
Table 15. Global Histone Deacetylase (HDAC) Inhibitors Value by Application (2015-2020)
Table 16. Global Histone Deacetylase (HDAC) Inhibitors Value Market Share by Application (2015-2020)
Table 17. Global Histone Deacetylase (HDAC) Inhibitors Sale Price by Application (2015-2020)
Table 18. Global Histone Deacetylase (HDAC) Inhibitors Sales by Company (2017-2019) (K MT)
Table 19. Global Histone Deacetylase (HDAC) Inhibitors Sales Market Share by Company (2017-2019)
Table 20. Global Histone Deacetylase (HDAC) Inhibitors Revenue by Company (2017-2019) ($ Millions)
Table 21. Global Histone Deacetylase (HDAC) Inhibitors Revenue Market Share by Company (2017-2019)
Table 22. Global Histone Deacetylase (HDAC) Inhibitors Sale Price by Company (2017-2019)
Table 23. Global Histone Deacetylase (HDAC) Inhibitors Manufacturing Base Distribution and Sales Area by Manufacturers
Table 24. Players Histone Deacetylase (HDAC) Inhibitors Products Offered
Table 25. Histone Deacetylase (HDAC) Inhibitors Concentration Ratio (CR3, CR5 and CR10) (2017-2019)
Table 26. Global Histone Deacetylase (HDAC) Inhibitors Consumption by Regions 2015-2020 (K MT)
Table 27. Global Histone Deacetylase (HDAC) Inhibitors Consumption Market Share by Regions 2015-2020
Table 28. Global Histone Deacetylase (HDAC) Inhibitors Value by Regions 2015-2020 ($ Millions)
Table 29. Global Histone Deacetylase (HDAC) Inhibitors Value Market Share by Regions 2015-2020
Table 30. Americas Histone Deacetylase (HDAC) Inhibitors Consumption by Countries (2015-2020) (K MT)
Table 31. Americas Histone Deacetylase (HDAC) Inhibitors Consumption Market Share by Countries (2015-2020)
Table 32. Americas Histone Deacetylase (HDAC) Inhibitors Value by Countries (2015-2020) ($ Millions)
Table 33. Americas Histone Deacetylase (HDAC) Inhibitors Value Market Share by Countries (2015-2020)
Table 34. Americas Histone Deacetylase (HDAC) Inhibitors Consumption by Type (2015-2020) (K MT)
Table 35. Americas Histone Deacetylase (HDAC) Inhibitors Consumption Market Share by Type (2015-2020)
Table 36. Americas Histone Deacetylase (HDAC) Inhibitors Consumption by Application (2015-2020) (K MT)
Table 37. Americas Histone Deacetylase (HDAC) Inhibitors Consumption Market Share by Application (2015-2020)
Table 38. APAC Histone Deacetylase (HDAC) Inhibitors Consumption by Regions (2015-2020) (K MT)
Table 39. APAC Histone Deacetylase (HDAC) Inhibitors Consumption Market Share by Regions (2015-2020)
Table 40. APAC Histone Deacetylase (HDAC) Inhibitors Value by Regions (2015-2020) ($ Millions)
Table 41. APAC Histone Deacetylase (HDAC) Inhibitors Value Market Share by Regions (2015-2020)
Table 42. APAC Histone Deacetylase (HDAC) Inhibitors Consumption by Type (2015-2020) (K MT)
Table 43. APAC Histone Deacetylase (HDAC) Inhibitors Consumption Market Share by Type (2015-2020)
Table 44. APAC Histone Deacetylase (HDAC) Inhibitors Consumption by Application (2015-2020) (K MT)
Table 45. APAC Histone Deacetylase (HDAC) Inhibitors Consumption Market Share by Application (2015-2020)
Table 46. Europe Histone Deacetylase (HDAC) Inhibitors Consumption by Countries (2015-2020) (K MT)
Table 47. Europe Histone Deacetylase (HDAC) Inhibitors Consumption Market Share by Countries (2015-2020)
Table 48. Europe Histone Deacetylase (HDAC) Inhibitors Value by Countries (2015-2020) ($ Millions)
Table 49. Europe Histone Deacetylase (HDAC) Inhibitors Value Market Share by Countries (2015-2020)
Table 50. Europe Histone Deacetylase (HDAC) Inhibitors Consumption by Type (2015-2020) (K MT)
Table 51. Europe Histone Deacetylase (HDAC) Inhibitors Consumption Market Share by Type (2015-2020)
Table 52. Europe Histone Deacetylase (HDAC) Inhibitors Consumption by Application (2015-2020) (K MT)
Table 53. Europe Histone Deacetylase (HDAC) Inhibitors Consumption Market Share by Application (2015-2020)
Table 54. Middle East & Africa Histone Deacetylase (HDAC) Inhibitors Consumption by Countries (2015-2020) (K MT)
Table 55. Middle East & Africa Histone Deacetylase (HDAC) Inhibitors Consumption Market Share by Countries (2015-2020)
Table 56. Middle East & Africa Histone Deacetylase (HDAC) Inhibitors Value by Countries (2015-2020) ($ Millions)
Table 57. Middle East & Africa Histone Deacetylase (HDAC) Inhibitors Value Market Share by Countries (2015-2020)
Table 58. Middle East & Africa Histone Deacetylase (HDAC) Inhibitors Consumption by Type (2015-2020) (K MT)
Table 59. Middle East & Africa Histone Deacetylase (HDAC) Inhibitors Consumption Market Share by Type (2015-2020)
Table 60. Middle East & Africa Histone Deacetylase (HDAC) Inhibitors Consumption by Application (2015-2020) (K MT)
Table 61. Middle East & Africa Histone Deacetylase (HDAC) Inhibitors Consumption Market Share by Application (2015-2020)
Table 62. Histone Deacetylase (HDAC) Inhibitors Distributors List
Table 63. Histone Deacetylase (HDAC) Inhibitors Customer List
Table 64. Global Histone Deacetylase (HDAC) Inhibitors Consumption Forecast by Countries (2021-2025) (K MT)
Table 65. Global Histone Deacetylase (HDAC) Inhibitors Consumption Market Forecast by Regions
Table 66. Global Histone Deacetylase (HDAC) Inhibitors Value Forecast by Countries (2021-2025) ($ Millions)
Table 67. Global Histone Deacetylase (HDAC) Inhibitors Value Market Share Forecast by Regions
Table 68. Global Histone Deacetylase (HDAC) Inhibitors Consumption Forecast by Type (2021-2025) (K MT)
Table 69. Global Histone Deacetylase (HDAC) Inhibitors Consumption Market Share Forecast by Type (2021-2025)
Table 70. Global Histone Deacetylase (HDAC) Inhibitors Value Forecast by Type (2021-2025) ($ Millions)
Table 71. Global Histone Deacetylase (HDAC) Inhibitors Value Market Share Forecast by Type (2021-2025)
Table 72. Global Histone Deacetylase (HDAC) Inhibitors Consumption Forecast by Application (2021-2025) (K MT)
Table 73. Global Histone Deacetylase (HDAC) Inhibitors Consumption Market Share Forecast by Application (2021-2025)
Table 74. Global Histone Deacetylase (HDAC) Inhibitors Value Forecast by Application (2021-2025) ($ Millions)
Table 75. Global Histone Deacetylase (HDAC) Inhibitors Value Market Share Forecast by Application (2021-2025)
Table 76. 4SC Product Offered
Table 77. 4SC Histone Deacetylase (HDAC) Inhibitors Sales (K MT), Revenue ($ Million), Price (USD/MT) and Gross Margin (2018-2020E)
Table 78. 4SC Main Business
Table 79. 4SC Latest Developments
Table 80. 4SC Basic Information, Company Total Revenue (in $ million), Histone Deacetylase (HDAC) Inhibitors Manufacturing Base, Sales Area and Its Competitors
Table 81. Novartis Product Offered
Table 82. Novartis Histone Deacetylase (HDAC) Inhibitors Sales (K MT), Revenue ($ Million), Price (USD/MT) and Gross Margin (2018-2020E)
Table 83. Novartis Main Business
Table 84. Novartis Latest Developments
Table 85. Novartis Basic Information, Company Total Revenue (in $ million), Histone Deacetylase (HDAC) Inhibitors Manufacturing Base, Sales Area and Its Competitors
Table 86. Acetylon Pharmaceuticals Product Offered
Table 87. Acetylon Pharmaceuticals Histone Deacetylase (HDAC) Inhibitors Sales (K MT), Revenue ($ Million), Price (USD/MT) and Gross Margin (2018-2020E)
Table 88. Acetylon Pharmaceuticals Main Business
Table 89. Acetylon Pharmaceuticals Latest Developments
Table 90. Acetylon Pharmaceuticals Basic Information, Company Total Revenue (in $ million), Histone Deacetylase (HDAC) Inhibitors Manufacturing Base, Sales Area and Its Competitors
Table 91. Chipscreen Biosciences Product Offered
Table 92. Chipscreen Biosciences Histone Deacetylase (HDAC) Inhibitors Sales (K MT), Revenue ($ Million), Price (USD/MT) and Gross Margin (2018-2020E)
Table 93. Chipscreen Biosciences Main Business
Table 94. Chipscreen Biosciences Latest Developments
Table 95. Chipscreen Biosciences Basic Information, Company Total Revenue (in $ million), Histone Deacetylase (HDAC) Inhibitors Manufacturing Base, Sales Area and Its Competitors
Table 96. Chroma Therapeutics Product Offered
Table 97. Chroma Therapeutics Histone Deacetylase (HDAC) Inhibitors Sales (K MT), Revenue ($ Million), Price (USD/MT) and Gross Margin (2018-2020E)
Table 98. Chroma Therapeutics Main Business
Table 99. Chroma Therapeutics Latest Developments
Table 100. Chroma Therapeutics Basic Information, Company Total Revenue (in $ million), Histone Deacetylase (HDAC) Inhibitors Manufacturing Base, Sales Area and Its Competitors
Table 101. Celleron Therapeutics Product Offered
Table 102. Celleron Therapeutics Histone Deacetylase (HDAC) Inhibitors Sales (K MT), Revenue ($ Million), Price (USD/MT) and Gross Margin (2018-2020E)
Table 103. Celleron Therapeutics Main Business
Table 104. Celleron Therapeutics Latest Developments
Table 105. Celleron Therapeutics Basic Information, Company Total Revenue (in $ million), Histone Deacetylase (HDAC) Inhibitors Manufacturing Base, Sales Area and Its Competitors
Table 106. MEI Pharma Product Offered
Table 107. MEI Pharma Basic Information, Company Total Revenue (in $ million), Histone Deacetylase (HDAC) Inhibitors Manufacturing Base, Sales Area and Its Competitors
Table 108. MEI Pharma Main Business
Table 109. MEI Pharma Latest Developments
Table 110. MEI Pharma Histone Deacetylase (HDAC) Inhibitors Sales (K MT), Revenue ($ Million), Price (USD/MT) and Gross Margin (2018-2020E)
Table 111. CrystalGenomics Product Offered
Table 112. CrystalGenomics Histone Deacetylase (HDAC) Inhibitors Sales (K MT), Revenue ($ Million), Price (USD/MT) and Gross Margin (2018-2020E)
Table 113. CrystalGenomics Main Business
Table 114. CrystalGenomics Latest Developments
Table 115. CrystalGenomics Basic Information, Company Total Revenue (in $ million), Histone Deacetylase (HDAC) Inhibitors Manufacturing Base, Sales Area and Its Competitors
Table 116. Mirati Therapeutics Product Offered
Table 117. Mirati Therapeutics Histone Deacetylase (HDAC) Inhibitors Sales (K MT), Revenue ($ Million), Price (USD/MT) and Gross Margin (2018-2020E)
Table 118. Mirati Therapeutics Main Business
Table 119. Mirati Therapeutics Latest Developments
Table 120. Mirati Therapeutics Basic Information, Company Total Revenue (in $ million), Histone Deacetylase (HDAC) Inhibitors Manufacturing Base, Sales Area and Its Competitors
Table 121. Curis Product Offered
Table 122. Curis Histone Deacetylase (HDAC) Inhibitors Sales (K MT), Revenue ($ Million), Price (USD/MT) and Gross Margin (2018-2020E)
Table 123. Curis Main Business
Table 124. Curis Latest Developments
Table 125. Curis Basic Information, Company Total Revenue (in $ million), Histone Deacetylase (HDAC) Inhibitors Manufacturing Base, Sales Area and Its Competitors
Table 126. Onxeo Product Offered
Table 127. Onxeo Histone Deacetylase (HDAC) Inhibitors Sales (K MT), Revenue ($ Million), Price (USD/MT) and Gross Margin (2018-2020E)
Table 128. Onxeo Main Business
Table 129. Onxeo Basic Information, Manufacturing Base, Sales Area and Its Competitors
Table 130. Onxeo Latest Developments
Table 131. TetraLogic Product Offered
Table 132. TetraLogic Histone Deacetylase (HDAC) Inhibitors Sales (K MT), Revenue ($ Million), Price (USD/MT) and Gross Margin (2018-2020E)
Table 133. TetraLogic Main Business
Table 134. TetraLogic Basic Information, Manufacturing Base, Sales Area and Its Competitors
Table 135. TetraLogic Latest Developments
Table 136. Repligen Product Offered
Table 137. Repligen Histone Deacetylase (HDAC) Inhibitors Sales (K MT), Revenue ($ Million), Price (USD/MT) and Gross Margin (2018-2020E)
Table 138. Repligen Main Business
Table 139. Repligen Latest Developments
Table 140. Repligen Basic Information, Manufacturing Base, Sales Area and Its Competitors
List of Figures
Figure 1. Picture of Histone Deacetylase (HDAC) Inhibitors
Figure 2. Histone Deacetylase (HDAC) Inhibitors Report Years Considered
Figure 3. Market Research Methodology
Figure 4. Global Histone Deacetylase (HDAC) Inhibitors Consumption Growth Rate 2015-2025 (K MT)
Figure 5. Global Histone Deacetylase (HDAC) Inhibitors Value Growth Rate 2015-2025 ($ Millions)
Figure 6. Product Picture of Fatty Acid
Figure 7. Product Picture of Hydroxamate
Figure 8. Product Picture of Cyclic Peptide
Figure 9. Product Picture of Benzamide
Figure 10. Global Histone Deacetylase (HDAC) Inhibitors Consumption Market Share by Type (2015-2020)
Figure 11. Global Histone Deacetylase (HDAC) Inhibitors Value Market Share by Type (2015-2020)
Figure 12. Histone Deacetylase (HDAC) Inhibitors Consumed in Treatment of Malignant Tumors
Figure 13. Global Histone Deacetylase (HDAC) Inhibitors Market: Treatment of Malignant Tumors (2015-2020) (K MT)
Figure 14. Global Histone Deacetylase (HDAC) Inhibitors Market: Treatment of Malignant Tumors (2015-2020) ($ Millions)
Figure 15. Histone Deacetylase (HDAC) Inhibitors Consumed in Chronic Disease Treatment
Figure 16. Global Histone Deacetylase (HDAC) Inhibitors Market: Chronic Disease Treatment (2015-2020) (K MT)
Figure 17. Global Histone Deacetylase (HDAC) Inhibitors Market: Chronic Disease Treatment (2015-2020) ($ Millions)
Figure 18. Histone Deacetylase (HDAC) Inhibitors Consumed in Others
Figure 19. Global Histone Deacetylase (HDAC) Inhibitors Market: Others (2015-2020) (K MT)
Figure 20. Global Histone Deacetylase (HDAC) Inhibitors Market: Others (2015-2020) ($ Millions)
Figure 21. Global Histone Deacetylase (HDAC) Inhibitors Consumption Market Share by Application (2015-2020)
Figure 22. Global Histone Deacetylase (HDAC) Inhibitors Value Market Share by Application (2015-2020)
Figure 23. Global Histone Deacetylase (HDAC) Inhibitors Sales Market Share by Company in 2017
Figure 24. Global Histone Deacetylase (HDAC) Inhibitors Sales Market Share by Company in 2019
Figure 25. Global Histone Deacetylase (HDAC) Inhibitors Revenue Market Share by Company in 2017
Figure 26. Global Histone Deacetylase (HDAC) Inhibitors Revenue Market Share by Company in 2019
Figure 27. Global Histone Deacetylase (HDAC) Inhibitors Sale Price by Company in 2019
Figure 28. Global Histone Deacetylase (HDAC) Inhibitors Consumption Market Share by Regions 2015-2020
Figure 29. Global Histone Deacetylase (HDAC) Inhibitors Value Market Share by Regions 2015-2020
Figure 30. Americas Histone Deacetylase (HDAC) Inhibitors Consumption 2015-2020 (K MT)
Figure 31. Americas Histone Deacetylase (HDAC) Inhibitors Value 2015-2020 ($ Millions)
Figure 32. APAC Histone Deacetylase (HDAC) Inhibitors Consumption 2015-2020 (K MT)
Figure 33. APAC Histone Deacetylase (HDAC) Inhibitors Value 2015-2020 ($ Millions)
Figure 34. Europe Histone Deacetylase (HDAC) Inhibitors Consumption 2015-2020 (K MT)
Figure 35. Europe Histone Deacetylase (HDAC) Inhibitors Value 2015-2020 ($ Millions)
Figure 36. Middle East & Africa Histone Deacetylase (HDAC) Inhibitors Consumption 2015-2020 (K MT)
Figure 37. Middle East & Africa Histone Deacetylase (HDAC) Inhibitors Value 2015-2020 ($ Millions)
Figure 38. Americas Histone Deacetylase (HDAC) Inhibitors Consumption Market Share by Countries in 2019
Figure 39. Americas Histone Deacetylase (HDAC) Inhibitors Value Market Share by Countries in 2019
Figure 40. Americas Histone Deacetylase (HDAC) Inhibitors Consumption Market Share by Type in 2019
Figure 41. Americas Histone Deacetylase (HDAC) Inhibitors Consumption Market Share by Application in 2019
Figure 42. United States Histone Deacetylase (HDAC) Inhibitors Consumption Growth 2015-2020 (K MT)
Figure 43. United States Histone Deacetylase (HDAC) Inhibitors Value Growth 2015-2020 ($ Millions)
Figure 44. Canada Histone Deacetylase (HDAC) Inhibitors Consumption Growth 2015-2020 (K MT)
Figure 45. Canada Histone Deacetylase (HDAC) Inhibitors Value Growth 2015-2020 ($ Millions)
Figure 46. Mexico Histone Deacetylase (HDAC) Inhibitors Consumption Growth 2015-2020 (K MT)
Figure 47. Mexico Histone Deacetylase (HDAC) Inhibitors Value Growth 2015-2020 ($ Millions)
Figure 48. APAC Histone Deacetylase (HDAC) Inhibitors Consumption Market Share by Countries in 2019
Figure 49. APAC Histone Deacetylase (HDAC) Inhibitors Value Market Share by Regions in 2019
Figure 50. APAC Histone Deacetylase (HDAC) Inhibitors Consumption Market Share by Type in 2019
Figure 51. APAC Histone Deacetylase (HDAC) Inhibitors Consumption Market Share by Application in 2019
Figure 52. China Histone Deacetylase (HDAC) Inhibitors Consumption Growth 2015-2020 (K MT)
Figure 53. China Histone Deacetylase (HDAC) Inhibitors Value Growth 2015-2020 ($ Millions)
Figure 54. Japan Histone Deacetylase (HDAC) Inhibitors Consumption Growth 2015-2020 (K MT)
Figure 55. Japan Histone Deacetylase (HDAC) Inhibitors Value Growth 2015-2020 ($ Millions)
Figure 56. Korea Histone Deacetylase (HDAC) Inhibitors Consumption Growth 2015-2020 (K MT)
Figure 57. Korea Histone Deacetylase (HDAC) Inhibitors Value Growth 2015-2020 ($ Millions)
Figure 58. Southeast Asia Histone Deacetylase (HDAC) Inhibitors Consumption Growth 2015-2020 (K MT)
Figure 59. Southeast Asia Histone Deacetylase (HDAC) Inhibitors Value Growth 2015-2020 ($ Millions)
Figure 60. India Histone Deacetylase (HDAC) Inhibitors Consumption Growth 2015-2020 (K MT)
Figure 61. India Histone Deacetylase (HDAC) Inhibitors Value Growth 2015-2020 ($ Millions)
Figure 62. Australia Histone Deacetylase (HDAC) Inhibitors Consumption Growth 2015-2020 (K MT)
Figure 63. Australia Histone Deacetylase (HDAC) Inhibitors Value Growth 2015-2020 ($ Millions)
Figure 64. Europe Histone Deacetylase (HDAC) Inhibitors Consumption Market Share by Countries in 2019
Figure 65. Europe Histone Deacetylase (HDAC) Inhibitors Value Market Share by Countries in 2019
Figure 66. Europe Histone Deacetylase (HDAC) Inhibitors Consumption Market Share by Type in 2019
Figure 67. Europe Histone Deacetylase (HDAC) Inhibitors Consumption Market Share by Application in 2019
Figure 68. Germany Histone Deacetylase (HDAC) Inhibitors Consumption Growth 2015-2020 (K MT)
Figure 69. Germany Histone Deacetylase (HDAC) Inhibitors Value Growth 2015-2020 ($ Millions)
Figure 70. France Histone Deacetylase (HDAC) Inhibitors Consumption Growth 2015-2020 (K MT)
Figure 71. France Histone Deacetylase (HDAC) Inhibitors Value Growth 2015-2020 ($ Millions)
Figure 72. UK Histone Deacetylase (HDAC) Inhibitors Consumption Growth 2015-2020 (K MT)
Figure 73. UK Histone Deacetylase (HDAC) Inhibitors Value Growth 2015-2020 ($ Millions)
Figure 74. Italy Histone Deacetylase (HDAC) Inhibitors Consumption Growth 2015-2020 (K MT)
Figure 75. Italy Histone Deacetylase (HDAC) Inhibitors Value Growth 2015-2020 ($ Millions)
Figure 76. Russia Histone Deacetylase (HDAC) Inhibitors Consumption Growth 2015-2020 (K MT)
Figure 77. Russia Histone Deacetylase (HDAC) Inhibitors Value Growth 2015-2020 ($ Millions)
Figure 78. Middle East & Africa Histone Deacetylase (HDAC) Inhibitors Consumption Market Share by Countries in 2019
Figure 79. Middle East & Africa Histone Deacetylase (HDAC) Inhibitors Value Market Share by Countries in 2019
Figure 80. Middle East & Africa Histone Deacetylase (HDAC) Inhibitors Consumption Market Share by Type in 2019
Figure 81. Middle East & Africa Histone Deacetylase (HDAC) Inhibitors Consumption Market Share by Application in 2019
Figure 82. Egypt Histone Deacetylase (HDAC) Inhibitors Consumption Growth 2015-2020 (K MT)
Figure 83. Egypt Histone Deacetylase (HDAC) Inhibitors Value Growth 2015-2020 ($ Millions)
Figure 84. South Africa Histone Deacetylase (HDAC) Inhibitors Consumption Growth 2015-2020 (K MT)
Figure 85. South Africa Histone Deacetylase (HDAC) Inhibitors Value Growth 2015-2020 ($ Millions)
Figure 86. Israel Histone Deacetylase (HDAC) Inhibitors Consumption Growth 2015-2020 (K MT)
Figure 87. Israel Histone Deacetylase (HDAC) Inhibitors Value Growth 2015-2020 ($ Millions)
Figure 88. Turkey Histone Deacetylase (HDAC) Inhibitors Consumption Growth 2015-2020 (K MT)
Figure 89. Turkey Histone Deacetylase (HDAC) Inhibitors Value Growth 2015-2020 ($ Millions)
Figure 90. GCC Countries Histone Deacetylase (HDAC) Inhibitors Consumption Growth 2015-2020 (K MT)
Figure 91. GCC Countries Histone Deacetylase (HDAC) Inhibitors Value Growth 2015-2020 ($ Millions)
Figure 92. Global Histone Deacetylase (HDAC) Inhibitors Consumption Growth Rate Forecast (2021-2025) (K MT)
Figure 93. Global Histone Deacetylase (HDAC) Inhibitors Value Growth Rate Forecast (2021-2025) ($ Millions)
Figure 94. Americas Histone Deacetylase (HDAC) Inhibitors Consumption 2021-2025 (K MT)
Figure 95. Americas Histone Deacetylase (HDAC) Inhibitors Value 2021-2025 ($ Millions)
Figure 96. APAC Histone Deacetylase (HDAC) Inhibitors Consumption 2021-2025 (K MT)
Figure 97. APAC Histone Deacetylase (HDAC) Inhibitors Value 2021-2025 ($ Millions)
Figure 98. Europe Histone Deacetylase (HDAC) Inhibitors Consumption 2021-2025 (K MT)
Figure 99. Europe Histone Deacetylase (HDAC) Inhibitors Value 2021-2025 ($ Millions)
Figure 100. Middle East & Africa Histone Deacetylase (HDAC) Inhibitors Consumption 2021-2025 (K MT)
Figure 101. Middle East & Africa Histone Deacetylase (HDAC) Inhibitors Value 2021-2025 ($ Millions)
Figure 102. United States Histone Deacetylase (HDAC) Inhibitors Consumption 2021-2025 (K MT)
Figure 103. United States Histone Deacetylase (HDAC) Inhibitors Value 2021-2025 ($ Millions)
Figure 104. Canada Histone Deacetylase (HDAC) Inhibitors Consumption 2021-2025 (K MT)
Figure 105. Canada Histone Deacetylase (HDAC) Inhibitors Value 2021-2025 ($ Millions)
Figure 106. Mexico Histone Deacetylase (HDAC) Inhibitors Consumption 2021-2025 (K MT)
Figure 107. Mexico Histone Deacetylase (HDAC) Inhibitors Value 2021-2025 ($ Millions)
Figure 108. Brazil Histone Deacetylase (HDAC) Inhibitors Consumption 2021-2025 (K MT)
Figure 109. Brazil Histone Deacetylase (HDAC) Inhibitors Value 2021-2025 ($ Millions)
Figure 110. China Histone Deacetylase (HDAC) Inhibitors Consumption 2021-2025 (K MT)
Figure 111. China Histone Deacetylase (HDAC) Inhibitors Value 2021-2025 ($ Millions)
Figure 112. Japan Histone Deacetylase (HDAC) Inhibitors Consumption 2021-2025 (K MT)
Figure 113. Japan Histone Deacetylase (HDAC) Inhibitors Value 2021-2025 ($ Millions)
Figure 114. Korea Histone Deacetylase (HDAC) Inhibitors Consumption 2021-2025 (K MT)
Figure 115. Korea Histone Deacetylase (HDAC) Inhibitors Value 2021-2025 ($ Millions)
Figure 116. Southeast Asia Histone Deacetylase (HDAC) Inhibitors Consumption 2021-2025 (K MT)
Figure 117. Southeast Asia Histone Deacetylase (HDAC) Inhibitors Value 2021-2025 ($ Millions)
Figure 118. India Histone Deacetylase (HDAC) Inhibitors Consumption 2021-2025 (K MT)
Figure 119. India Histone Deacetylase (HDAC) Inhibitors Value 2021-2025 ($ Millions)
Figure 120. Australia Histone Deacetylase (HDAC) Inhibitors Consumption 2021-2025 (K MT)
Figure 121. Australia Histone Deacetylase (HDAC) Inhibitors Value 2021-2025 ($ Millions)
Figure 122. Germany Histone Deacetylase (HDAC) Inhibitors Consumption 2021-2025 (K MT)
Figure 123. Germany Histone Deacetylase (HDAC) Inhibitors Value 2021-2025 ($ Millions)
Figure 124. France Histone Deacetylase (HDAC) Inhibitors Consumption 2021-2025 (K MT)
Figure 125. France Histone Deacetylase (HDAC) Inhibitors Value 2021-2025 ($ Millions)
Figure 126. UK Histone Deacetylase (HDAC) Inhibitors Consumption 2021-2025 (K MT)
Figure 127. UK Histone Deacetylase (HDAC) Inhibitors Value 2021-2025 ($ Millions)
Figure 128. Italy Histone Deacetylase (HDAC) Inhibitors Consumption 2021-2025 (K MT)
Figure 129. Italy Histone Deacetylase (HDAC) Inhibitors Value 2021-2025 ($ Millions)
Figure 130. Russia Histone Deacetylase (HDAC) Inhibitors Consumption 2021-2025 (K MT)
Figure 131. Russia Histone Deacetylase (HDAC) Inhibitors Value 2021-2025 ($ Millions)
Figure 132. Spain Histone Deacetylase (HDAC) Inhibitors Consumption 2021-2025 (K MT)
Figure 133. Spain Histone Deacetylase (HDAC) Inhibitors Value 2021-2025 ($ Millions)
Figure 134. Egypt Histone Deacetylase (HDAC) Inhibitors Consumption 2021-2025 (K MT)
Figure 135. Egypt Histone Deacetylase (HDAC) Inhibitors Value 2021-2025 ($ Millions)
Figure 136. South Africa Histone Deacetylase (HDAC) Inhibitors Consumption 2021-2025 (K MT)
Figure 137. South Africa Histone Deacetylase (HDAC) Inhibitors Value 2021-2025 ($ Millions)
Figure 138. Israel Histone Deacetylase (HDAC) Inhibitors Consumption 2021-2025 (K MT)
Figure 139. Israel Histone Deacetylase (HDAC) Inhibitors Value 2021-2025 ($ Millions)
Figure 140. Turkey Histone Deacetylase (HDAC) Inhibitors Consumption 2021-2025 (K MT)
Figure 141. Turkey Histone Deacetylase (HDAC) Inhibitors Value 2021-2025 ($ Millions)
Figure 142. GCC Countries Histone Deacetylase (HDAC) Inhibitors Consumption 2021-2025 (K MT)
Figure 143. GCC Countries Histone Deacetylase (HDAC) Inhibitors Value 2021-2025 ($ Millions)
Figure 144. 4SC Histone Deacetylase (HDAC) Inhibitors Market Share (2018-2020)
Figure 145. Novartis Histone Deacetylase (HDAC) Inhibitors Market Share (2018-2020)
Figure 146. Acetylon Pharmaceuticals Histone Deacetylase (HDAC) Inhibitors Market Share (2018-2020)
Figure 147. Chipscreen Biosciences Histone Deacetylase (HDAC) Inhibitors Market Share (2018-2020)
Figure 148. Chroma Therapeutics Histone Deacetylase (HDAC) Inhibitors Market Share (2018-2020)
Figure 149. Celleron Therapeutics Histone Deacetylase (HDAC) Inhibitors Market Share (2018-2020)
Figure 150. MEI Pharma Histone Deacetylase (HDAC) Inhibitors Market Share (2018-2020)
Figure 151. CrystalGenomics Histone Deacetylase (HDAC) Inhibitors Market Share (2018-2020)
Figure 152. Mirati Therapeutics Histone Deacetylase (HDAC) Inhibitors Market Share (2018-2020)
Figure 153. Curis Histone Deacetylase (HDAC) Inhibitors Market Share (2018-2020)
Figure 154. Onxeo Histone Deacetylase (HDAC) Inhibitors Market Share (2018-2020)
Figure 155. TetraLogic Histone Deacetylase (HDAC) Inhibitors Market Share (2018-2020)
Figure 156. Repligen Histone Deacetylase (HDAC) Inhibitors Market Share (2018-2020)
Reason to Buy
- Current and future of Pharma & Healthcare Market outlook in the developed and emerging markets
- Highlights key business priorities in order to assist companies to realign their business strategies
- The segment that is expected to dominate the Pharma & Healthcare Market
- Regions that are expected to witness the fastest growth during the forecast period
- Identify the latest developments, Pharma & Healthcare Market shares, and strategies employed by the major market players
- Save and reduce time carrying out entry-level research by identifying the growth, size, leading players and segments in the global Pharma & Healthcare Market
- Develop/modify business expansion plans by using substantial growth offering developed and emerging markets